Single-Cell Multi-Omics for Safer, More Effective Cell & Gene Therapies.
Unlock a deeper understanding of your therapeutic product with integrated single-cell RNA, DNA, and immunophenotypic analysis. This multiomic approach enables you to characterize clonotypes within your drug product, monitor shifts in drug product fitness, and assess gene edits. Targeted single-cell RNA analysis reveals how your engineered cells function—beyond the edit.
By capturing targeted gene expression at the single-cell level, researchers can connect vector copy number (VCN) with transgene expression, uncover endogenous transcriptional responses, and identify RNA-level signatures tied to potency, persistence, and exhaustion.